Ursodiol Tablet
Product Images NDC 70771-1407

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 70771-1407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (F1a82fbb 58eb 4b71 83e2 265d11788c3d 01)

Chemical structure of Ursodiol showing its molecular arrangement with multiple rings and functional groups, including hydroxyl and carboxyl groups.*

FDA Label Image

250 mg (F1a82fbb 58eb 4b71 83e2 265d11788c3d 02)

Ursodiol Tablets USP 250 mg oral tablets label with NDC 70771-1407-1, showing a tablet image marked '1127'. The label indicates a count of 100 tablets, Rx only, and is manufactured by Cadila Healthcare Ltd., Baddi, India for Zydus Lifesciences Limited. Storage and dosage instructions are partially visible along with a barcode on the left.*

FDA Label Image

500 mg (F1a82fbb 58eb 4b71 83e2 265d11788c3d 03)

Ursodiol Tablets USP 500 mg oral tablets label showing the NDC 70771-1408-1. The label displays two white, oval scored tablets embossed with '1128.' The package contains 100 tablets, produced by Zydus Lifesciences Limited. The label includes dosage strength, usage note for Primary Biliary Cholangitis, and storage recommendations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.